Penumbra Inc at Piper Sandler Healthcare Conference Transcript
' -
All right. Afternoon, everybody. Thanks so much for joining us. Matt O'Brien, I cover Medtech here at Piper. Very, very fortunate to have the Penumbra team with us today. We've got Adam, who's the CEO and then Jason, who is Vice President of IR and biz dev. I think Cecilia is in the audience as well as far as folks from Penumbra that are here. So I really do appreciate you guys coming all the way across country.
Yes. Thanks for having us.
Questions & Answers
' -
Excellent. So let's start with Q3, which is really good, especially on the peripheral side. The peripheral business did really well. The thing that was interesting was how well it did, but I don't think you really got the benefit from the 600
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
